nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Ezetimibe—atherosclerosis	0.0891	0.131	CbGbCtD
Nifedipine—ABCC2—Ezetimibe—atherosclerosis	0.0405	0.0595	CbGbCtD
Nifedipine—ABCC2—Simvastatin—atherosclerosis	0.0377	0.0553	CbGbCtD
Nifedipine—ABCC2—Pravastatin—atherosclerosis	0.0368	0.0541	CbGbCtD
Nifedipine—ABCC2—Lovastatin—atherosclerosis	0.0368	0.0541	CbGbCtD
Nifedipine—CYP3A7—Simvastatin—atherosclerosis	0.0251	0.0369	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0251	0.0369	CbGbCtD
Nifedipine—CYP3A7—Lovastatin—atherosclerosis	0.0246	0.0361	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0246	0.0361	CbGbCtD
Nifedipine—CYP2B6—Simvastatin—atherosclerosis	0.0239	0.0351	CbGbCtD
Nifedipine—CYP3A5—Rosuvastatin—atherosclerosis	0.0203	0.0298	CbGbCtD
Nifedipine—CYP3A5—Simvastatin—atherosclerosis	0.0189	0.0277	CbGbCtD
Nifedipine—CYP3A5—Pravastatin—atherosclerosis	0.0185	0.0271	CbGbCtD
Nifedipine—CYP3A5—Lovastatin—atherosclerosis	0.0185	0.0271	CbGbCtD
Nifedipine—CYP2C8—Simvastatin—atherosclerosis	0.0181	0.0266	CbGbCtD
Nifedipine—CYP2C8—Lovastatin—atherosclerosis	0.0177	0.0261	CbGbCtD
Nifedipine—CYP2C8—Pravastatin—atherosclerosis	0.0177	0.0261	CbGbCtD
Nifedipine—CYP2D6—Niacin—atherosclerosis	0.0146	0.0215	CbGbCtD
Nifedipine—CYP2C9—Rosuvastatin—atherosclerosis	0.0136	0.02	CbGbCtD
Nifedipine—ABCB1—Ezetimibe—atherosclerosis	0.0132	0.0194	CbGbCtD
Nifedipine—CYP2C9—Simvastatin—atherosclerosis	0.0126	0.0186	CbGbCtD
Nifedipine—CYP2C9—Pravastatin—atherosclerosis	0.0124	0.0182	CbGbCtD
Nifedipine—CYP2C9—Lovastatin—atherosclerosis	0.0124	0.0182	CbGbCtD
Nifedipine—ABCB1—Simvastatin—atherosclerosis	0.0123	0.018	CbGbCtD
Nifedipine—ABCB1—Lovastatin—atherosclerosis	0.012	0.0176	CbGbCtD
Nifedipine—ABCB1—Pravastatin—atherosclerosis	0.012	0.0176	CbGbCtD
Nifedipine—CYP2D6—Simvastatin—atherosclerosis	0.0116	0.017	CbGbCtD
Nifedipine—CYP2D6—Lovastatin—atherosclerosis	0.0113	0.0166	CbGbCtD
Nifedipine—CYP2D6—Pravastatin—atherosclerosis	0.0113	0.0166	CbGbCtD
Nifedipine—CYP3A4—Ezetimibe—atherosclerosis	0.00791	0.0116	CbGbCtD
Nifedipine—CYP3A4—Rosuvastatin—atherosclerosis	0.00791	0.0116	CbGbCtD
Nifedipine—CYP3A4—Simvastatin—atherosclerosis	0.00735	0.0108	CbGbCtD
Nifedipine—CYP3A4—Pravastatin—atherosclerosis	0.0072	0.0106	CbGbCtD
Nifedipine—CYP3A4—Lovastatin—atherosclerosis	0.0072	0.0106	CbGbCtD
Nifedipine—CACNA1S—cardiovascular system—atherosclerosis	0.00112	0.0505	CbGeAlD
Nifedipine—Nimodipine—AHR—atherosclerosis	0.00108	1	CrCbGaD
Nifedipine—CALM2—artery—atherosclerosis	0.00102	0.0463	CbGeAlD
Nifedipine—CALM1—artery—atherosclerosis	0.00102	0.0461	CbGeAlD
Nifedipine—CALM2—endothelium—atherosclerosis	0.000865	0.0391	CbGeAlD
Nifedipine—CALM1—endothelium—atherosclerosis	0.000861	0.0389	CbGeAlD
Nifedipine—CALM2—blood vessel—atherosclerosis	0.000798	0.0361	CbGeAlD
Nifedipine—CALM1—blood vessel—atherosclerosis	0.000794	0.0359	CbGeAlD
Nifedipine—CACNA1H—cardiovascular system—atherosclerosis	0.00071	0.0321	CbGeAlD
Nifedipine—CACNB2—cardiovascular system—atherosclerosis	0.000671	0.0303	CbGeAlD
Nifedipine—CACNA2D1—cardiovascular system—atherosclerosis	0.00063	0.0285	CbGeAlD
Nifedipine—CACNA1C—connective tissue—atherosclerosis	0.000622	0.0281	CbGeAlD
Nifedipine—CACNA1D—cardiovascular system—atherosclerosis	0.000586	0.0265	CbGeAlD
Nifedipine—CACNA2D1—adipose tissue—atherosclerosis	0.000555	0.0251	CbGeAlD
Nifedipine—CACNA1C—cardiovascular system—atherosclerosis	0.000541	0.0245	CbGeAlD
Nifedipine—CACNA1C—adipose tissue—atherosclerosis	0.000477	0.0216	CbGeAlD
Nifedipine—CYP3A7—liver—atherosclerosis	0.000468	0.0212	CbGeAlD
Nifedipine—CYP2A6—adipose tissue—atherosclerosis	0.000463	0.021	CbGeAlD
Nifedipine—CACNA1H—liver—atherosclerosis	0.000439	0.0199	CbGeAlD
Nifedipine—ABCC3—adipose tissue—atherosclerosis	0.000434	0.0196	CbGeAlD
Nifedipine—CACNB2—liver—atherosclerosis	0.000415	0.0188	CbGeAlD
Nifedipine—CALM2—connective tissue—atherosclerosis	0.000409	0.0185	CbGeAlD
Nifedipine—CALM1—connective tissue—atherosclerosis	0.000407	0.0184	CbGeAlD
Nifedipine—CALM3—adipose tissue—atherosclerosis	0.0004	0.0181	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000398	0.018	CbGeAlD
Nifedipine—CACNA2D1—liver—atherosclerosis	0.000389	0.0176	CbGeAlD
Nifedipine—CACNA1D—liver—atherosclerosis	0.000363	0.0164	CbGeAlD
Nifedipine—CALM2—cardiovascular system—atherosclerosis	0.000356	0.0161	CbGeAlD
Nifedipine—CALM1—cardiovascular system—atherosclerosis	0.000354	0.016	CbGeAlD
Nifedipine—CYP2A6—liver—atherosclerosis	0.000325	0.0147	CbGeAlD
Nifedipine—ABCB1—blood vessel—atherosclerosis	0.000317	0.0143	CbGeAlD
Nifedipine—CALM2—adipose tissue—atherosclerosis	0.000314	0.0142	CbGeAlD
Nifedipine—CALM1—adipose tissue—atherosclerosis	0.000312	0.0141	CbGeAlD
Nifedipine—ABCC3—liver—atherosclerosis	0.000304	0.0138	CbGeAlD
Nifedipine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000301	0.00171	CcSEcCtD
Nifedipine—Anaemia—Ezetimibe—atherosclerosis	0.0003	0.0017	CcSEcCtD
Nifedipine—Tinnitus—Pravastatin—atherosclerosis	0.000299	0.0017	CcSEcCtD
Nifedipine—Malaise—Lovastatin—atherosclerosis	0.000298	0.00169	CcSEcCtD
Nifedipine—Flushing—Pravastatin—atherosclerosis	0.000298	0.00169	CcSEcCtD
Nifedipine—Cardiac disorder—Pravastatin—atherosclerosis	0.000298	0.00169	CcSEcCtD
Nifedipine—Muscle spasms—Simvastatin—atherosclerosis	0.000297	0.00168	CcSEcCtD
Nifedipine—Vertigo—Lovastatin—atherosclerosis	0.000297	0.00168	CcSEcCtD
Nifedipine—Angioedema—Ezetimibe—atherosclerosis	0.000296	0.00168	CcSEcCtD
Nifedipine—Angiopathy—Niacin—atherosclerosis	0.000296	0.00168	CcSEcCtD
Nifedipine—Leukopenia—Lovastatin—atherosclerosis	0.000296	0.00168	CcSEcCtD
Nifedipine—Chills—Niacin—atherosclerosis	0.000292	0.00166	CcSEcCtD
Nifedipine—Malaise—Ezetimibe—atherosclerosis	0.000292	0.00166	CcSEcCtD
Nifedipine—Vision blurred—Simvastatin—atherosclerosis	0.000291	0.00165	CcSEcCtD
Nifedipine—Arrhythmia—Niacin—atherosclerosis	0.000291	0.00165	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00029	0.00164	CcSEcCtD
Nifedipine—Tremor—Simvastatin—atherosclerosis	0.00029	0.00164	CcSEcCtD
Nifedipine—Alopecia—Niacin—atherosclerosis	0.000288	0.00163	CcSEcCtD
Nifedipine—Chills—Pravastatin—atherosclerosis	0.000288	0.00163	CcSEcCtD
Nifedipine—Insomnia—Rosuvastatin—atherosclerosis	0.000288	0.00163	CcSEcCtD
Nifedipine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000287	0.00163	CcSEcCtD
Nifedipine—Arrhythmia—Pravastatin—atherosclerosis	0.000287	0.00163	CcSEcCtD
Nifedipine—Palpitations—Ezetimibe—atherosclerosis	0.000286	0.00162	CcSEcCtD
Nifedipine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000286	0.00162	CcSEcCtD
Nifedipine—Anaemia—Simvastatin—atherosclerosis	0.000286	0.00162	CcSEcCtD
Nifedipine—Malnutrition—Niacin—atherosclerosis	0.000284	0.00161	CcSEcCtD
Nifedipine—Erythema—Niacin—atherosclerosis	0.000284	0.00161	CcSEcCtD
Nifedipine—Alopecia—Pravastatin—atherosclerosis	0.000284	0.00161	CcSEcCtD
Nifedipine—Cough—Ezetimibe—atherosclerosis	0.000283	0.0016	CcSEcCtD
Nifedipine—Angioedema—Simvastatin—atherosclerosis	0.000282	0.0016	CcSEcCtD
Nifedipine—Chest pain—Lovastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Nifedipine—Arthralgia—Lovastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Nifedipine—Myalgia—Lovastatin—atherosclerosis	0.000281	0.0016	CcSEcCtD
Nifedipine—Anxiety—Lovastatin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Nifedipine—CALM3—liver—atherosclerosis	0.00028	0.0127	CbGeAlD
Nifedipine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Nifedipine—Flatulence—Niacin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Nifedipine—Malaise—Simvastatin—atherosclerosis	0.000279	0.00158	CcSEcCtD
Nifedipine—Tension—Niacin—atherosclerosis	0.000278	0.00158	CcSEcCtD
Nifedipine—Discomfort—Lovastatin—atherosclerosis	0.000278	0.00158	CcSEcCtD
Nifedipine—Vertigo—Simvastatin—atherosclerosis	0.000278	0.00157	CcSEcCtD
Nifedipine—Leukopenia—Simvastatin—atherosclerosis	0.000277	0.00157	CcSEcCtD
Nifedipine—Arthralgia—Ezetimibe—atherosclerosis	0.000276	0.00156	CcSEcCtD
Nifedipine—Myalgia—Ezetimibe—atherosclerosis	0.000276	0.00156	CcSEcCtD
Nifedipine—Chest pain—Ezetimibe—atherosclerosis	0.000276	0.00156	CcSEcCtD
Nifedipine—Nervousness—Niacin—atherosclerosis	0.000276	0.00156	CcSEcCtD
Nifedipine—Flatulence—Pravastatin—atherosclerosis	0.000275	0.00156	CcSEcCtD
Nifedipine—Dry mouth—Lovastatin—atherosclerosis	0.000275	0.00156	CcSEcCtD
Nifedipine—Tension—Pravastatin—atherosclerosis	0.000274	0.00155	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000274	0.00155	CcSEcCtD
Nifedipine—Dysgeusia—Pravastatin—atherosclerosis	0.000274	0.00155	CcSEcCtD
Nifedipine—Muscle spasms—Niacin—atherosclerosis	0.000273	0.00155	CcSEcCtD
Nifedipine—Discomfort—Ezetimibe—atherosclerosis	0.000273	0.00155	CcSEcCtD
Nifedipine—Constipation—Rosuvastatin—atherosclerosis	0.000272	0.00154	CcSEcCtD
Nifedipine—Pain—Rosuvastatin—atherosclerosis	0.000272	0.00154	CcSEcCtD
Nifedipine—Confusional state—Lovastatin—atherosclerosis	0.000272	0.00154	CcSEcCtD
Nifedipine—Nervousness—Pravastatin—atherosclerosis	0.000271	0.00154	CcSEcCtD
Nifedipine—Dry mouth—Ezetimibe—atherosclerosis	0.00027	0.00153	CcSEcCtD
Nifedipine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00027	0.00153	CcSEcCtD
Nifedipine—Muscle spasms—Pravastatin—atherosclerosis	0.000269	0.00152	CcSEcCtD
Nifedipine—Vision blurred—Niacin—atherosclerosis	0.000267	0.00152	CcSEcCtD
Nifedipine—Confusional state—Ezetimibe—atherosclerosis	0.000267	0.00151	CcSEcCtD
Nifedipine—CYP2B6—cardiovascular system—atherosclerosis	0.000265	0.012	CbGeAlD
Nifedipine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000264	0.0015	CcSEcCtD
Nifedipine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000264	0.0015	CcSEcCtD
Nifedipine—Vision blurred—Pravastatin—atherosclerosis	0.000263	0.00149	CcSEcCtD
Nifedipine—Arthralgia—Simvastatin—atherosclerosis	0.000263	0.00149	CcSEcCtD
Nifedipine—Chest pain—Simvastatin—atherosclerosis	0.000263	0.00149	CcSEcCtD
Nifedipine—Myalgia—Simvastatin—atherosclerosis	0.000263	0.00149	CcSEcCtD
Nifedipine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000262	0.00149	CcSEcCtD
Nifedipine—Anxiety—Simvastatin—atherosclerosis	0.000262	0.00149	CcSEcCtD
Nifedipine—CYP2C9—cardiovascular system—atherosclerosis	0.000262	0.0119	CbGeAlD
Nifedipine—Tremor—Pravastatin—atherosclerosis	0.000262	0.00148	CcSEcCtD
Nifedipine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00026	0.00148	CcSEcCtD
Nifedipine—Discomfort—Simvastatin—atherosclerosis	0.00026	0.00147	CcSEcCtD
Nifedipine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000259	0.00147	CcSEcCtD
Nifedipine—Angioedema—Niacin—atherosclerosis	0.000259	0.00147	CcSEcCtD
Nifedipine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000259	0.00147	CcSEcCtD
Nifedipine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000259	0.00147	CcSEcCtD
Nifedipine—Anaemia—Pravastatin—atherosclerosis	0.000258	0.00146	CcSEcCtD
Nifedipine—Anorexia—Lovastatin—atherosclerosis	0.000257	0.00146	CcSEcCtD
Nifedipine—Skin disorder—Ezetimibe—atherosclerosis	0.000257	0.00146	CcSEcCtD
Nifedipine—Angioedema—Pravastatin—atherosclerosis	0.000255	0.00145	CcSEcCtD
Nifedipine—Vertigo—Niacin—atherosclerosis	0.000255	0.00145	CcSEcCtD
Nifedipine—Syncope—Niacin—atherosclerosis	0.000254	0.00144	CcSEcCtD
Nifedipine—Confusional state—Simvastatin—atherosclerosis	0.000254	0.00144	CcSEcCtD
Nifedipine—Leukopenia—Niacin—atherosclerosis	0.000254	0.00144	CcSEcCtD
Nifedipine—Urticaria—Rosuvastatin—atherosclerosis	0.000253	0.00143	CcSEcCtD
Nifedipine—Oedema—Simvastatin—atherosclerosis	0.000252	0.00143	CcSEcCtD
Nifedipine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000252	0.00143	CcSEcCtD
Nifedipine—Malaise—Pravastatin—atherosclerosis	0.000252	0.00143	CcSEcCtD
Nifedipine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000252	0.00143	CcSEcCtD
Nifedipine—Vertigo—Pravastatin—atherosclerosis	0.000251	0.00142	CcSEcCtD
Nifedipine—Palpitations—Niacin—atherosclerosis	0.000251	0.00142	CcSEcCtD
Nifedipine—Leukopenia—Pravastatin—atherosclerosis	0.00025	0.00142	CcSEcCtD
Nifedipine—Loss of consciousness—Niacin—atherosclerosis	0.000249	0.00141	CcSEcCtD
Nifedipine—CYP2E1—cardiovascular system—atherosclerosis	0.000248	0.0112	CbGeAlD
Nifedipine—Cough—Niacin—atherosclerosis	0.000248	0.0014	CcSEcCtD
Nifedipine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000247	0.0014	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000246	0.00139	CcSEcCtD
Nifedipine—Insomnia—Lovastatin—atherosclerosis	0.000244	0.00138	CcSEcCtD
Nifedipine—Cough—Pravastatin—atherosclerosis	0.000244	0.00138	CcSEcCtD
Nifedipine—ABCC2—liver—atherosclerosis	0.000243	0.011	CbGeAlD
Nifedipine—Paraesthesia—Lovastatin—atherosclerosis	0.000242	0.00137	CcSEcCtD
Nifedipine—Arthralgia—Niacin—atherosclerosis	0.000242	0.00137	CcSEcCtD
Nifedipine—Myalgia—Niacin—atherosclerosis	0.000242	0.00137	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000241	0.00137	CcSEcCtD
Nifedipine—Anorexia—Simvastatin—atherosclerosis	0.00024	0.00136	CcSEcCtD
Nifedipine—Dyspnoea—Lovastatin—atherosclerosis	0.00024	0.00136	CcSEcCtD
Nifedipine—CYP1A1—adipose tissue—atherosclerosis	0.00024	0.0109	CbGeAlD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00024	0.00136	CcSEcCtD
Nifedipine—Insomnia—Ezetimibe—atherosclerosis	0.000239	0.00136	CcSEcCtD
Nifedipine—Myalgia—Pravastatin—atherosclerosis	0.000238	0.00135	CcSEcCtD
Nifedipine—Chest pain—Pravastatin—atherosclerosis	0.000238	0.00135	CcSEcCtD
Nifedipine—Arthralgia—Pravastatin—atherosclerosis	0.000238	0.00135	CcSEcCtD
Nifedipine—Paraesthesia—Ezetimibe—atherosclerosis	0.000237	0.00135	CcSEcCtD
Nifedipine—Dyspepsia—Lovastatin—atherosclerosis	0.000237	0.00135	CcSEcCtD
Nifedipine—Anxiety—Pravastatin—atherosclerosis	0.000237	0.00134	CcSEcCtD
Nifedipine—Dry mouth—Niacin—atherosclerosis	0.000236	0.00134	CcSEcCtD
Nifedipine—Dyspnoea—Ezetimibe—atherosclerosis	0.000236	0.00134	CcSEcCtD
Nifedipine—Discomfort—Pravastatin—atherosclerosis	0.000235	0.00133	CcSEcCtD
Nifedipine—CYP3A5—adipose tissue—atherosclerosis	0.000235	0.0106	CbGeAlD
Nifedipine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000234	0.00133	CcSEcCtD
Nifedipine—Decreased appetite—Lovastatin—atherosclerosis	0.000234	0.00133	CcSEcCtD
Nifedipine—Dyspepsia—Ezetimibe—atherosclerosis	0.000233	0.00132	CcSEcCtD
Nifedipine—Fatigue—Lovastatin—atherosclerosis	0.000232	0.00132	CcSEcCtD
Nifedipine—Oedema—Niacin—atherosclerosis	0.000232	0.00131	CcSEcCtD
Nifedipine—Anaphylactic shock—Niacin—atherosclerosis	0.000232	0.00131	CcSEcCtD
Nifedipine—Pain—Lovastatin—atherosclerosis	0.000231	0.00131	CcSEcCtD
Nifedipine—Constipation—Lovastatin—atherosclerosis	0.000231	0.00131	CcSEcCtD
Nifedipine—Confusional state—Pravastatin—atherosclerosis	0.00023	0.0013	CcSEcCtD
Nifedipine—Decreased appetite—Ezetimibe—atherosclerosis	0.00023	0.0013	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00023	0.0013	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Asthenia—Rosuvastatin—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Insomnia—Simvastatin—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Oedema—Pravastatin—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Fatigue—Ezetimibe—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Shock—Niacin—atherosclerosis	0.000228	0.00129	CcSEcCtD
Nifedipine—Paraesthesia—Simvastatin—atherosclerosis	0.000226	0.00128	CcSEcCtD
Nifedipine—Constipation—Ezetimibe—atherosclerosis	0.000226	0.00128	CcSEcCtD
Nifedipine—Pain—Ezetimibe—atherosclerosis	0.000226	0.00128	CcSEcCtD
Nifedipine—Tachycardia—Niacin—atherosclerosis	0.000226	0.00128	CcSEcCtD
Nifedipine—Pruritus—Rosuvastatin—atherosclerosis	0.000225	0.00128	CcSEcCtD
Nifedipine—Skin disorder—Niacin—atherosclerosis	0.000225	0.00128	CcSEcCtD
Nifedipine—Dyspnoea—Simvastatin—atherosclerosis	0.000225	0.00128	CcSEcCtD
Nifedipine—Hyperhidrosis—Niacin—atherosclerosis	0.000224	0.00127	CcSEcCtD
Nifedipine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000223	0.00127	CcSEcCtD
Nifedipine—Feeling abnormal—Lovastatin—atherosclerosis	0.000222	0.00126	CcSEcCtD
Nifedipine—Dyspepsia—Simvastatin—atherosclerosis	0.000222	0.00126	CcSEcCtD
Nifedipine—Anorexia—Niacin—atherosclerosis	0.000221	0.00125	CcSEcCtD
Nifedipine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000221	0.00125	CcSEcCtD
Nifedipine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00022	0.00125	CcSEcCtD
Nifedipine—CALM2—liver—atherosclerosis	0.00022	0.00996	CbGeAlD
Nifedipine—Decreased appetite—Simvastatin—atherosclerosis	0.000219	0.00124	CcSEcCtD
Nifedipine—CALM1—liver—atherosclerosis	0.000219	0.00991	CbGeAlD
Nifedipine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000218	0.00124	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000218	0.00123	CcSEcCtD
Nifedipine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000218	0.00123	CcSEcCtD
Nifedipine—Fatigue—Simvastatin—atherosclerosis	0.000217	0.00123	CcSEcCtD
Nifedipine—Anorexia—Pravastatin—atherosclerosis	0.000217	0.00123	CcSEcCtD
Nifedipine—Hypotension—Niacin—atherosclerosis	0.000216	0.00123	CcSEcCtD
Nifedipine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000216	0.00123	CcSEcCtD
Nifedipine—Constipation—Simvastatin—atherosclerosis	0.000216	0.00122	CcSEcCtD
Nifedipine—Pain—Simvastatin—atherosclerosis	0.000216	0.00122	CcSEcCtD
Nifedipine—Urticaria—Lovastatin—atherosclerosis	0.000214	0.00121	CcSEcCtD
Nifedipine—Abdominal pain—Lovastatin—atherosclerosis	0.000213	0.00121	CcSEcCtD
Nifedipine—Body temperature increased—Lovastatin—atherosclerosis	0.000213	0.00121	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000211	0.0012	CcSEcCtD
Nifedipine—Dizziness—Rosuvastatin—atherosclerosis	0.00021	0.00119	CcSEcCtD
Nifedipine—Urticaria—Ezetimibe—atherosclerosis	0.00021	0.00119	CcSEcCtD
Nifedipine—Insomnia—Niacin—atherosclerosis	0.000209	0.00119	CcSEcCtD
Nifedipine—Body temperature increased—Ezetimibe—atherosclerosis	0.000209	0.00119	CcSEcCtD
Nifedipine—Abdominal pain—Ezetimibe—atherosclerosis	0.000209	0.00119	CcSEcCtD
Nifedipine—Paraesthesia—Niacin—atherosclerosis	0.000208	0.00118	CcSEcCtD
Nifedipine—Feeling abnormal—Simvastatin—atherosclerosis	0.000208	0.00118	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000208	0.00118	CcSEcCtD
Nifedipine—Dyspnoea—Niacin—atherosclerosis	0.000206	0.00117	CcSEcCtD
Nifedipine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000206	0.00117	CcSEcCtD
Nifedipine—Insomnia—Pravastatin—atherosclerosis	0.000206	0.00117	CcSEcCtD
Nifedipine—Somnolence—Niacin—atherosclerosis	0.000206	0.00117	CcSEcCtD
Nifedipine—Paraesthesia—Pravastatin—atherosclerosis	0.000205	0.00116	CcSEcCtD
Nifedipine—Dyspepsia—Niacin—atherosclerosis	0.000204	0.00116	CcSEcCtD
Nifedipine—Dyspnoea—Pravastatin—atherosclerosis	0.000203	0.00115	CcSEcCtD
Nifedipine—Decreased appetite—Niacin—atherosclerosis	0.000201	0.00114	CcSEcCtD
Nifedipine—Dyspepsia—Pravastatin—atherosclerosis	0.000201	0.00114	CcSEcCtD
Nifedipine—Rash—Rosuvastatin—atherosclerosis	0.000201	0.00114	CcSEcCtD
Nifedipine—Dermatitis—Rosuvastatin—atherosclerosis	0.0002	0.00114	CcSEcCtD
Nifedipine—Urticaria—Simvastatin—atherosclerosis	0.0002	0.00114	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Niacin—atherosclerosis	0.0002	0.00113	CcSEcCtD
Nifedipine—Abdominal pain—Simvastatin—atherosclerosis	0.000199	0.00113	CcSEcCtD
Nifedipine—Body temperature increased—Simvastatin—atherosclerosis	0.000199	0.00113	CcSEcCtD
Nifedipine—Headache—Rosuvastatin—atherosclerosis	0.000199	0.00113	CcSEcCtD
Nifedipine—Hypersensitivity—Lovastatin—atherosclerosis	0.000199	0.00113	CcSEcCtD
Nifedipine—Decreased appetite—Pravastatin—atherosclerosis	0.000198	0.00112	CcSEcCtD
Nifedipine—Pain—Niacin—atherosclerosis	0.000198	0.00112	CcSEcCtD
Nifedipine—Fatigue—Pravastatin—atherosclerosis	0.000197	0.00111	CcSEcCtD
Nifedipine—Constipation—Pravastatin—atherosclerosis	0.000195	0.00111	CcSEcCtD
Nifedipine—Pain—Pravastatin—atherosclerosis	0.000195	0.00111	CcSEcCtD
Nifedipine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000195	0.0011	CcSEcCtD
Nifedipine—Asthenia—Lovastatin—atherosclerosis	0.000193	0.0011	CcSEcCtD
Nifedipine—Pruritus—Lovastatin—atherosclerosis	0.000191	0.00108	CcSEcCtD
Nifedipine—Asthenia—Ezetimibe—atherosclerosis	0.00019	0.00108	CcSEcCtD
Nifedipine—Gastrointestinal pain—Niacin—atherosclerosis	0.000189	0.00107	CcSEcCtD
Nifedipine—Nausea—Rosuvastatin—atherosclerosis	0.000189	0.00107	CcSEcCtD
Nifedipine—Feeling abnormal—Pravastatin—atherosclerosis	0.000188	0.00107	CcSEcCtD
Nifedipine—Pruritus—Ezetimibe—atherosclerosis	0.000187	0.00106	CcSEcCtD
Nifedipine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000186	0.00106	CcSEcCtD
Nifedipine—Hypersensitivity—Simvastatin—atherosclerosis	0.000186	0.00105	CcSEcCtD
Nifedipine—Diarrhoea—Lovastatin—atherosclerosis	0.000184	0.00105	CcSEcCtD
Nifedipine—Urticaria—Niacin—atherosclerosis	0.000184	0.00104	CcSEcCtD
Nifedipine—Body temperature increased—Niacin—atherosclerosis	0.000183	0.00104	CcSEcCtD
Nifedipine—Abdominal pain—Niacin—atherosclerosis	0.000183	0.00104	CcSEcCtD
Nifedipine—CYP2C8—liver—atherosclerosis	0.000182	0.00825	CbGeAlD
Nifedipine—Urticaria—Pravastatin—atherosclerosis	0.000181	0.00103	CcSEcCtD
Nifedipine—Asthenia—Simvastatin—atherosclerosis	0.000181	0.00103	CcSEcCtD
Nifedipine—Diarrhoea—Ezetimibe—atherosclerosis	0.000181	0.00103	CcSEcCtD
Nifedipine—Abdominal pain—Pravastatin—atherosclerosis	0.00018	0.00102	CcSEcCtD
Nifedipine—Body temperature increased—Pravastatin—atherosclerosis	0.00018	0.00102	CcSEcCtD
Nifedipine—Pruritus—Simvastatin—atherosclerosis	0.000178	0.00101	CcSEcCtD
Nifedipine—Dizziness—Lovastatin—atherosclerosis	0.000178	0.00101	CcSEcCtD
Nifedipine—Dizziness—Ezetimibe—atherosclerosis	0.000175	0.000992	CcSEcCtD
Nifedipine—Diarrhoea—Simvastatin—atherosclerosis	0.000173	0.000979	CcSEcCtD
Nifedipine—Vomiting—Lovastatin—atherosclerosis	0.000171	0.000972	CcSEcCtD
Nifedipine—CYP1A2—liver—atherosclerosis	0.000171	0.00772	CbGeAlD
Nifedipine—Hypersensitivity—Niacin—atherosclerosis	0.000171	0.000968	CcSEcCtD
Nifedipine—Rash—Lovastatin—atherosclerosis	0.00017	0.000964	CcSEcCtD
Nifedipine—Dermatitis—Lovastatin—atherosclerosis	0.00017	0.000963	CcSEcCtD
Nifedipine—Headache—Lovastatin—atherosclerosis	0.000169	0.000958	CcSEcCtD
Nifedipine—CYP1A1—liver—atherosclerosis	0.000168	0.00762	CbGeAlD
Nifedipine—Vomiting—Ezetimibe—atherosclerosis	0.000168	0.000954	CcSEcCtD
Nifedipine—Hypersensitivity—Pravastatin—atherosclerosis	0.000168	0.000953	CcSEcCtD
Nifedipine—Dizziness—Simvastatin—atherosclerosis	0.000167	0.000946	CcSEcCtD
Nifedipine—Rash—Ezetimibe—atherosclerosis	0.000167	0.000946	CcSEcCtD
Nifedipine—Dermatitis—Ezetimibe—atherosclerosis	0.000167	0.000945	CcSEcCtD
Nifedipine—Asthenia—Niacin—atherosclerosis	0.000166	0.000942	CcSEcCtD
Nifedipine—Headache—Ezetimibe—atherosclerosis	0.000166	0.00094	CcSEcCtD
Nifedipine—CYP3A5—liver—atherosclerosis	0.000165	0.00745	CbGeAlD
Nifedipine—Pruritus—Niacin—atherosclerosis	0.000164	0.000929	CcSEcCtD
Nifedipine—CYP2B6—liver—atherosclerosis	0.000164	0.0074	CbGeAlD
Nifedipine—Asthenia—Pravastatin—atherosclerosis	0.000164	0.000928	CcSEcCtD
Nifedipine—CYP2C9—liver—atherosclerosis	0.000162	0.00733	CbGeAlD
Nifedipine—Pruritus—Pravastatin—atherosclerosis	0.000161	0.000915	CcSEcCtD
Nifedipine—Vomiting—Simvastatin—atherosclerosis	0.00016	0.000909	CcSEcCtD
Nifedipine—Nausea—Lovastatin—atherosclerosis	0.00016	0.000908	CcSEcCtD
Nifedipine—Rash—Simvastatin—atherosclerosis	0.000159	0.000902	CcSEcCtD
Nifedipine—Dermatitis—Simvastatin—atherosclerosis	0.000159	0.000901	CcSEcCtD
Nifedipine—Diarrhoea—Niacin—atherosclerosis	0.000158	0.000899	CcSEcCtD
Nifedipine—Headache—Simvastatin—atherosclerosis	0.000158	0.000896	CcSEcCtD
Nifedipine—Nausea—Ezetimibe—atherosclerosis	0.000157	0.000891	CcSEcCtD
Nifedipine—Diarrhoea—Pravastatin—atherosclerosis	0.000156	0.000885	CcSEcCtD
Nifedipine—CYP2E1—liver—atherosclerosis	0.000154	0.00695	CbGeAlD
Nifedipine—Dizziness—Niacin—atherosclerosis	0.000153	0.000868	CcSEcCtD
Nifedipine—Dizziness—Pravastatin—atherosclerosis	0.000151	0.000855	CcSEcCtD
Nifedipine—Nausea—Simvastatin—atherosclerosis	0.00015	0.00085	CcSEcCtD
Nifedipine—Vomiting—Niacin—atherosclerosis	0.000147	0.000835	CcSEcCtD
Nifedipine—Rash—Niacin—atherosclerosis	0.000146	0.000828	CcSEcCtD
Nifedipine—Dermatitis—Niacin—atherosclerosis	0.000146	0.000827	CcSEcCtD
Nifedipine—Headache—Niacin—atherosclerosis	0.000145	0.000823	CcSEcCtD
Nifedipine—Vomiting—Pravastatin—atherosclerosis	0.000145	0.000822	CcSEcCtD
Nifedipine—Rash—Pravastatin—atherosclerosis	0.000144	0.000815	CcSEcCtD
Nifedipine—Dermatitis—Pravastatin—atherosclerosis	0.000144	0.000815	CcSEcCtD
Nifedipine—Headache—Pravastatin—atherosclerosis	0.000143	0.00081	CcSEcCtD
Nifedipine—ABCB1—cardiovascular system—atherosclerosis	0.000141	0.0064	CbGeAlD
Nifedipine—Nausea—Niacin—atherosclerosis	0.000138	0.00078	CcSEcCtD
Nifedipine—Nausea—Pravastatin—atherosclerosis	0.000135	0.000768	CcSEcCtD
Nifedipine—ABCB1—adipose tissue—atherosclerosis	0.000125	0.00564	CbGeAlD
Nifedipine—CYP3A4—liver—atherosclerosis	0.000124	0.00559	CbGeAlD
Nifedipine—CYP2D6—liver—atherosclerosis	0.000122	0.0055	CbGeAlD
Nifedipine—ABCB1—liver—atherosclerosis	8.75e-05	0.00396	CbGeAlD
Nifedipine—CALM3—Innate Immune System—IL6—atherosclerosis	3.58e-06	3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CAV1—atherosclerosis	3.58e-06	3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APOA1—atherosclerosis	3.57e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PPARG—atherosclerosis	3.57e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—INS—atherosclerosis	3.57e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—INS—atherosclerosis	3.57e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AGT—atherosclerosis	3.56e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AGT—atherosclerosis	3.56e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1B—atherosclerosis	3.56e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GPX1—atherosclerosis	3.56e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—AKT1—atherosclerosis	3.55e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—AKT1—atherosclerosis	3.55e-06	2.97e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—atherosclerosis	3.53e-06	2.96e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.51e-06	2.94e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—INS—atherosclerosis	3.5e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CD36—atherosclerosis	3.5e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APOE—atherosclerosis	3.49e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APOE—atherosclerosis	3.49e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—LEP—atherosclerosis	3.49e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—LEP—atherosclerosis	3.49e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—ALB—atherosclerosis	3.47e-06	2.91e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CD36—atherosclerosis	3.46e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—IL6—atherosclerosis	3.46e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—IL6—atherosclerosis	3.46e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CAV1—atherosclerosis	3.46e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CAV1—atherosclerosis	3.46e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APOA1—atherosclerosis	3.45e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APOA1—atherosclerosis	3.45e-06	2.89e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARA—atherosclerosis	3.45e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ESR1—atherosclerosis	3.45e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1B—atherosclerosis	3.44e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1B—atherosclerosis	3.44e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.44e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—atherosclerosis	3.42e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—atherosclerosis	3.42e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.41e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—F2—atherosclerosis	3.4e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ALB—atherosclerosis	3.4e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ALB—atherosclerosis	3.4e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.39e-06	2.84e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ALB—atherosclerosis	3.38e-06	2.83e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—AKT1—atherosclerosis	3.37e-06	2.83e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AGT—atherosclerosis	3.34e-06	2.8e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ESR1—atherosclerosis	3.33e-06	2.79e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ESR1—atherosclerosis	3.33e-06	2.79e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—NOS3—atherosclerosis	3.32e-06	2.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NFKB1—atherosclerosis	3.32e-06	2.78e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.31e-06	2.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—AKT1—atherosclerosis	3.3e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—F2—atherosclerosis	3.29e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—F2—atherosclerosis	3.29e-06	2.76e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.28e-06	2.75e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOE—atherosclerosis	3.27e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—atherosclerosis	3.27e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ALB—atherosclerosis	3.27e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ALB—atherosclerosis	3.27e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK8—atherosclerosis	3.26e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOB—atherosclerosis	3.26e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CG—atherosclerosis	3.26e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—NOS3—atherosclerosis	3.26e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.25e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—NOS3—atherosclerosis	3.25e-06	2.72e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CAV1—atherosclerosis	3.24e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—NOS3—atherosclerosis	3.23e-06	2.71e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOA1—atherosclerosis	3.23e-06	2.71e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARA—atherosclerosis	3.22e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NFKB1—atherosclerosis	3.21e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NFKB1—atherosclerosis	3.21e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—INS—atherosclerosis	3.21e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ALB—atherosclerosis	3.21e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—atherosclerosis	3.19e-06	2.68e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—atherosclerosis	3.19e-06	2.68e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.17e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—atherosclerosis	3.17e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK8—atherosclerosis	3.16e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK8—atherosclerosis	3.16e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	3.15e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	3.15e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AGT—atherosclerosis	3.15e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—NOS3—atherosclerosis	3.13e-06	2.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—NOS3—atherosclerosis	3.13e-06	2.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	3.12e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AGT—atherosclerosis	3.12e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—LPL—atherosclerosis	3.12e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—INS—atherosclerosis	3.08e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOE—atherosclerosis	3.08e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—NOS3—atherosclerosis	3.07e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—atherosclerosis	3.07e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—atherosclerosis	3.07e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.06e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOE—atherosclerosis	3.06e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.06e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.05e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.04e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.04e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCL2—atherosclerosis	3.03e-06	2.54e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.03e-06	2.54e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—atherosclerosis	3.02e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.02e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	3.02e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	3.02e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—STAT3—atherosclerosis	2.98e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—INS—atherosclerosis	2.98e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—INS—atherosclerosis	2.98e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF1—atherosclerosis	2.98e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—atherosclerosis	2.98e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.97e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CD36—atherosclerosis	2.96e-06	2.48e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—atherosclerosis	2.96e-06	2.48e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.95e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ALB—atherosclerosis	2.94e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCL2—atherosclerosis	2.94e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCL2—atherosclerosis	2.94e-06	2.46e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—STAT3—atherosclerosis	2.89e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—STAT3—atherosclerosis	2.89e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1—atherosclerosis	2.89e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1—atherosclerosis	2.89e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—atherosclerosis	2.86e-06	2.4e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—atherosclerosis	2.86e-06	2.4e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK3—atherosclerosis	2.85e-06	2.39e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—atherosclerosis	2.85e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	2.83e-06	2.37e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—NOS3—atherosclerosis	2.81e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—atherosclerosis	2.81e-06	2.35e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.81e-06	2.35e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—INS—atherosclerosis	2.8e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.78e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.76e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—atherosclerosis	2.76e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—atherosclerosis	2.76e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—atherosclerosis	2.76e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARA—atherosclerosis	2.75e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	2.74e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	2.74e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—atherosclerosis	2.7e-06	2.27e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—atherosclerosis	2.69e-06	2.25e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AGT—atherosclerosis	2.67e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—atherosclerosis	2.67e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—atherosclerosis	2.67e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—atherosclerosis	2.66e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—INS—atherosclerosis	2.63e-06	2.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—atherosclerosis	2.63e-06	2.21e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.63e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—atherosclerosis	2.62e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—atherosclerosis	2.62e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOE—atherosclerosis	2.61e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—INS—atherosclerosis	2.61e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAV1—atherosclerosis	2.59e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOA1—atherosclerosis	2.58e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.57e-06	2.16e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—atherosclerosis	2.56e-06	2.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—atherosclerosis	2.55e-06	2.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—atherosclerosis	2.55e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—atherosclerosis	2.55e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOB—atherosclerosis	2.52e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—atherosclerosis	2.47e-06	2.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—atherosclerosis	2.47e-06	2.07e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—atherosclerosis	2.45e-06	2.05e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.45e-06	2.05e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—atherosclerosis	2.41e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—LPL—atherosclerosis	2.41e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—atherosclerosis	2.4e-06	2.01e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—atherosclerosis	2.39e-06	2.01e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.36e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.35e-06	1.97e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—atherosclerosis	2.32e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—atherosclerosis	2.32e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.31e-06	1.94e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.29e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CD36—atherosclerosis	2.29e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—atherosclerosis	2.28e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.28e-06	1.91e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.24e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—INS—atherosclerosis	2.23e-06	1.87e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—atherosclerosis	2.21e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—atherosclerosis	2.21e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—atherosclerosis	2.17e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.17e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NFKB1—atherosclerosis	2.15e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.12e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.11e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK8—atherosclerosis	2.11e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—atherosclerosis	2.1e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—atherosclerosis	2.1e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—atherosclerosis	2.1e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.09e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—atherosclerosis	2.08e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NFKB1—atherosclerosis	2.08e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NFKB1—atherosclerosis	2.08e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—atherosclerosis	2.07e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AGT—atherosclerosis	2.06e-06	1.72e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—atherosclerosis	2.05e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK8—atherosclerosis	2.04e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK8—atherosclerosis	2.04e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—atherosclerosis	2.04e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—atherosclerosis	2.04e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—atherosclerosis	2.02e-06	1.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—atherosclerosis	2.02e-06	1.69e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOE—atherosclerosis	2.02e-06	1.69e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAV1—atherosclerosis	2e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.99e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.96e-06	1.64e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—atherosclerosis	1.95e-06	1.63e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—atherosclerosis	1.93e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—atherosclerosis	1.92e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—atherosclerosis	1.92e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—atherosclerosis	1.89e-06	1.59e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—atherosclerosis	1.88e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—atherosclerosis	1.88e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—atherosclerosis	1.87e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—atherosclerosis	1.87e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—atherosclerosis	1.86e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—atherosclerosis	1.86e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—atherosclerosis	1.86e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—atherosclerosis	1.86e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—atherosclerosis	1.84e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.82e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.79e-06	1.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—atherosclerosis	1.79e-06	1.5e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—atherosclerosis	1.78e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—atherosclerosis	1.78e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—atherosclerosis	1.78e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.76e-06	1.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—atherosclerosis	1.73e-06	1.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—atherosclerosis	1.73e-06	1.45e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—INS—atherosclerosis	1.72e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—atherosclerosis	1.72e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—atherosclerosis	1.72e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—atherosclerosis	1.58e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.53e-06	1.28e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.51e-06	1.27e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.5e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—atherosclerosis	1.49e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—atherosclerosis	1.49e-06	1.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—atherosclerosis	1.44e-06	1.21e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—atherosclerosis	1.44e-06	1.21e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—atherosclerosis	1.41e-06	1.18e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.38e-06	1.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—atherosclerosis	1.35e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—atherosclerosis	1.3e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—atherosclerosis	1.3e-06	1.09e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—atherosclerosis	1.29e-06	1.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—atherosclerosis	1.24e-06	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	1.01e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—atherosclerosis	1.13e-06	9.44e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.06e-06	8.9e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.05e-06	8.82e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—atherosclerosis	9e-07	7.54e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—atherosclerosis	6.94e-07	5.82e-06	CbGpPWpGaD
